Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Po-Wei Chiu
Institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
Observed institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
ORCID:
0009-0001-5257-4511
Observed ORCID:
0009-0001-5257-4511
OpenAlex ID:
A5137798526
Cefiderocol nonsusceptibility among carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii : data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) program
2026
·
Po-Wei Chiu
, Jiun-Ling Wang
, et al.
·
Antimicrobial Agents and Chemotherapy
·
6
PDF
Cefiderocol non-susceptibility among carbapenem-resistant Enterobacterales: Data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) programme
2026
·
Po-Wei Chiu
, Jiun-Ling Wang
, et al.
·
International Journal of Antimicrobial Agents
·
1
Real-world outcomes among people receiving bictegravir/emtricitabine/tenofovir alafenamide: A comparison between those with and without advanced HIV-1 disease
2026
·
Tsung-Yu Tsai
, Chin-Shiang Tsai
, et al.
·
Journal of Infection and Public Health
Virologic response to bictegravir/emtricitabine/tenofovir alafenamide in people with advanced HIV-1 disease: A propensity-weighted multicentre cohort study
2026
·
Tsung-Yu Tsai
, Chin-Shiang Tsai
, et al.
·
International Journal of Antimicrobial Agents
PDF
Dual susceptibility to hepatitis A and B among people newly diagnosed with HIV in Taiwan during the vaccination era: A multicenter study
2026
·
Po-Wei Chiu
, Tsung-Yu Tsai
, et al.
·
International Journal of Infectious Diseases
Show more works
View as search
Works count:
5
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type